Monashee Investment Management LLC Bellus Health Inc. Transaction History

Monashee Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$8.22 - $10.76 $1.77 Million - $2.31 Million	215,000 Added 716.67%	245,000 $2.01 Million
Q3 2022 Nov 01, 2022	BUY	$8.95 - $12.0 $268,500 - $360,000	30,000 New	30,000 $317,000
Q1 2022 May 12, 2022	SELL	$5.56 - $7.99 $1.39 Million - $2 Million	-250,000 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$5.26 - $8.3 $1.32 Million - $2.08 Million	250,000 New	250,000 $2.01 Million
Q4 2019 Feb 12, 2020	SELL	$5.76 - $7.6 $172,800 - $228,000	-30,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$6.24 - $8.84 $187,200 - $265,200	30,000 New	30,000 $192,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.